Search results
Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC
Zacks via Yahoo Finance· 7 months agoPuma Biotechnology PBYI announced that its pipeline candidate alisertib was granted the Orphan Drug...
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y
Zacks via Yahoo Finance· 12 months agoPuma Biotechnology PBYI reported first-quarter 2023 earnings of 9 cents per share, in contrast to...
Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates
Zacks via Yahoo Finance· 2 months agoPuma Biotechnology, Inc. PBYI reported fourth-quarter 2023 adjusted earnings of 31 cents per share,...
Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Puma Biotechnology, Inc. (NASDAQ:PBYI) shares would be relieved that the share price...
Puma Biotechnology's (NASDAQ:PBYI) investors will be pleased with their decent 96% return over the...
Simply Wall St. via Yahoo Finance· 1 year agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Why Puma Biotechnology, Inc. (NASDAQ:PBYI) Looks Like A Quality Company
Simply Wall St. via Yahoo Finance· 1 year agoWhile some investors are already well versed in financial metrics (hat tip), this article is for...
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Profit Outlook
Simply Wall St. via Yahoo Finance· 2 years agoWith the business potentially at an important milestone, we thought we'd take a closer look at Puma...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y
Zacks via Yahoo Finance· 2 months agoRepligen Corporation RGEN reported fourth-quarter 2023 adjusted earnings per share of 33 cents,...
Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
Zacks via Yahoo Finance· 3 months agoMesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for...